Is Walgreens' High-Yielding Dividend Safe?

Source The Motley Fool

If the dividend yield for a stock you are considering exceeds 10%, you should be taking a long, hard look at the business to determine whether that payout is safe. If it's safe, the odds are good other investors would be buying up such a deal (and reducing the yield as a result). A dividend that high generates significant income, which boosts overall returns offers a great buffer during challenging market conditions.

Walgreens Boots Alliance (NASDAQ: WBA) slashed its dividend earlier this year. However, because the stock price fell significantly following the cut, its yield remains high -- at around 12.1% right now. At such a high rate, an investment of roughly $8,300 would result in $1,000 in dividends on an annual basis. But what if Walgreens cuts the dividend again? Then your investment is likely to take a big hit both on dividend and on share price.

Let's take a closer look to see whether Walgreens (reduced) payout is manageable, and determine if investors should brace for another potential cut in the near future.

Walgreens is still struggling with profitability

A big red flag for dividend investors is if a company can't stay out of the red. When that happens, dividend cuts tend to follow. Eventually, a suspension of the payout occurs if management doesn't see a way to turn things around.

In three of the past four quarters, Walgreens reported an operating loss. For its most recent fiscal year, which ended on Aug. 31, the company's operating loss totaled $14.1 billion. Of that, $12.7 billion was due to non-cash goodwill impairment charges. If you exclude those one-time charges, then its operating loss would have been approximately $1.4 billion -- less than the $6.9 billion loss it incurred a year earlier.

While that's an improvement, it may not provide much comfort to investors who want some confidence that the dividend is sustainable.

A troubling cash situation suggests more drastic changes could be coming for Walgreens

Walgreens is also in a tough cash position, which may only exacerbate concerns about its dividend. The company has been looking at asset sales as a way to boost its cash flow because its operating results haven't been strong. In the trailing 12 months, Walgreens' operating cash flow has come in at just over $1 billion, but its free cash flow has been negative. At its current dividend rate, Walgreens is paying approximately $864 million in cash dividends over the course of a full year.

Given the company's investments into growing its healthcare business and launching primary care clinics, the business needs to be in a much better position in terms of cash to balance both its growth aspirations and its dividend payments. But at this point, Walgreens may need to make a decision: Does it prioritize the dividend, or does it focus more on growth? Balancing both doesn't appear to be a viable scenario, at least not for much longer.

CEO Tim Wentworth slashed the dividend in January after being on the job for just a few months. Now, with more time to assess the company's situation, more drastic changes could be coming for Walgreens. The company is already planning to shut 1,200 pharmacy retail locations over the next few years, but that may not be enough to get its operations back into the black.

Investors shouldn't rely on Walgreens' dividend

I wouldn't suggest investing in Walgreens for its dividend. In five years, the stock has lost more than 85% of its value, and that's a big reason the yield is so high even with a dividend cut earlier in the year. Unless you are OK with a lot of risk and have faith in the company's new CEO, you may be better off steering clear of Walgreens, as there are plenty of safer dividend stocks to choose from right now.

As tempting as the yield may appear to be, there is real danger that the dividend could be cut or suspended at any time, given the uncertainty the business faces both in the short term and the long term.

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you buy stock in Walgreens Boots Alliance, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Walgreens Boots Alliance wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $894,029!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of November 18, 2024

David Jagielski has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Natural Gas sinks to pivotal level as China’s demand slumpsNatural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
Author  FXStreet
Jul 01, Mon
Natural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
placeholder
Bank of Japan governor Kazuo Ueda flags AI as a threat to financial stabilityKazuo Ueda, Governor of the Bank of Japan (BoJ), has warned that artificial intelligence (AI) poses a serious threat to financial stability.
Author  Cryptopolitan
Yesterday 08: 35
Kazuo Ueda, Governor of the Bank of Japan (BoJ), has warned that artificial intelligence (AI) poses a serious threat to financial stability.
placeholder
Morgan Stanley upgrades insurer Lemonade to 'equal-weight'Investing.com - Morgan Stanley on Wednesday said it was upgrading insurer Lemonade Inc (NYSE:LMND) to "equal-weight" from "underweight" and raised its price target to $42 from $23.
Author  Investing.com
Yesterday 12: 14
Investing.com - Morgan Stanley on Wednesday said it was upgrading insurer Lemonade Inc (NYSE:LMND) to "equal-weight" from "underweight" and raised its price target to $42 from $23.
placeholder
Crude Oil edges up, in second consecutive attempt to overcome $70Crude Oil prices are trying to break above $70 for a second consecutive day, fueled by headlines that Russia has launched a ballistic missile into Ukraine for the first time in the war, Bloomberg reports.
Author  FXStreet
Yesterday 12: 21
Crude Oil prices are trying to break above $70 for a second consecutive day, fueled by headlines that Russia has launched a ballistic missile into Ukraine for the first time in the war, Bloomberg reports.
placeholder
Crypto ETFs for XRP, SOL, and DOGE? The race heats upThe crypto Exchange-Traded Fund (ETF) race is heating up after the major success of Bitcoin spot ETF launch in the US. In a latest post, Nate Geraci, president of The ETF Store, suggested that the applications for Solana (SOL), Ripple’s XRP, HBAR, and even Cardano (ADA) or Avalanche (AVAX) ETFs are now in the mix
Author  Cryptopolitan
Yesterday 12: 22
The crypto Exchange-Traded Fund (ETF) race is heating up after the major success of Bitcoin spot ETF launch in the US. In a latest post, Nate Geraci, president of The ETF Store, suggested that the applications for Solana (SOL), Ripple’s XRP, HBAR, and even Cardano (ADA) or Avalanche (AVAX) ETFs are now in the mix
goTop
quote